GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS(159938),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

159938 GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS

Closed 05-22 15:00:00

0.61

-0.01

-1.14%

High0.62	Low0.60	Vol62.02M
Open0.61	D1 Closing0.61	Amplitude1.96%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O37.64M	T/O Rate--	Tradable Shares0.00
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"159938","market":"SZ","secType":"STK","nameCN":"GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS","latestPrice":0.606,"timestamp":1779433413000,"preClose":0.613,"halted":0,"volume":62022534,"delay":0,"changeRate":-0.0114,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-0.007,"latestTime":"05-22 15:00:00","open":0.613,"high":0.615,"low":0.603,"amount":37638400,"amplitude":0.0196,"askPrice":0.606,"askSize":1950,"bidPrice":0.605,"bidSize":4541,"shortable":0,"etf":1,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1779672600000},"marketStatusCode":5,"adr":0,"adjPreClose":0.613,"symbolType":"fund","openAndCloseTimeList":[[1779413400000,1779420600000],[1779426000000,1779433200000]],"highLimit":0.674,"lowLimit":0.552,"ibTradeSell":false,"ibTradeBuySell":true,"isCdr":false,"pbRate":0,"committee":0.457546,"marketValue":0,"turnoverRate":0,"status":1,"nextConnectDate":"Northbound have stopped. The next trading day is UTC+8 2026-05-26.","floatMarketCap":0},"requestUrl":"/m/hq/s/159938/wiki","defaultTab":"wiki","newsList":[{"id":"1177550158","title":"Huangzhong District Hosts Inaugural Traditional Chinese (Tibetan) Medicine Wellness Culture Promotion Event","url":"https://stock-news.laohu8.com/highlight/detail?id=1177550158","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177550158?lang=en_us&edition=fundamental","pubTime":"2026-05-23 01:50","pubTimestamp":1779472231,"startTime":"0","endTime":"0","summary":"On May 21, the inaugural Traditional Chinese (Tibetan) Medicine Wellness Culture Promotion Event was held at the Huangzhong District Hospital of Traditional Chinese Medicine in Xining City's...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","BK1515","BK1161","09939","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190980395","title":"Qinhao Pharma Faces Additional Information Requests from CSRC Ahead of Planned Hong Kong Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1190980395","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190980395?lang=en_us&edition=fundamental","pubTime":"2026-05-22 22:16","pubTimestamp":1779459394,"startTime":"0","endTime":"0","summary":"The China Securities Regulatory Commission (CSRC) has published a notice regarding supplementary material requirements for overseas issuance and listing filings for the period of May 18 to May 22,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","09939","BK1515","VXUS","159938","BK1161","BK4585","BK4588","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117218537","title":"HENLIUS's Serplulimab Injection Receives Positive CHMP Opinion from EMA","url":"https://stock-news.laohu8.com/highlight/detail?id=1117218537","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117218537?lang=en_us&edition=fundamental","pubTime":"2026-05-22 21:56","pubTimestamp":1779458184,"startTime":"0","endTime":"0","summary":"HENLIUS (02696) has announced that its independently developed Serplulimab Injection (marketed as Hansizhuang® in China and HETRONIFLY® in the EU) has received a positive opinion from the European...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","HK0000306685.HKD","BK1161","HK0000306701.USD","159938","HK0000320264.USD","09939","HK0000320223.HKD","02696","BK1574","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103214915","title":"BAIYUNSHAN PH (00874) Announces Completion of RMB 10 Billion Receivables Securitization by Guangzhou Pharmaceutical","url":"https://stock-news.laohu8.com/highlight/detail?id=1103214915","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103214915?lang=en_us&edition=fundamental","pubTime":"2026-05-22 17:36","pubTimestamp":1779442598,"startTime":"0","endTime":"0","summary":"BAIYUNSHAN PH (00874) has announced that on April 27, 2026, Guangzhou Pharmaceutical entered into a \"Xingye Yuanrong-Guangzhou Pharmaceutical Receivables Phase 5 Asset-Backed Special Plan Underlying...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","BK0096","BK1197","BK0196","BK0028","BK0070","00874","09939","BK1161","BK1574","BK0188","BK0097","BK0183","BK1191","BK1606","BK1515","BK0175","BK1521","600332","BK0239","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137846209","title":"Traditional Chinese and Tibetan Medicine Wellness Culture Promoted Across Huangzhong, Qinghai","url":"https://stock-news.laohu8.com/highlight/detail?id=1137846209","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137846209?lang=en_us&edition=fundamental","pubTime":"2026-05-21 21:09","pubTimestamp":1779368987,"startTime":"0","endTime":"0","summary":"On May 21st, the inaugural Traditional Chinese (Tibetan) Medicine Wellness Culture Promotion event commenced at the Huangzhong District Hospital of Traditional Chinese Medicine in Xining, Qinghai...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","159938","09939","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143082196","title":"Policy Support Boosts Innovative Drugs, Fullgoal's Hong Kong Stock Connect Healthcare Fund Nears End of Subscription","url":"https://stock-news.laohu8.com/highlight/detail?id=1143082196","media":"Deep News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143082196?lang=en_us&edition=fundamental","pubTime":"2026-05-21 12:01","pubTimestamp":1779336108,"startTime":"0","endTime":"0","summary":"Recently, China's innovative drug sector has received significant positive developments. Hengrui Pharmaceuticals has entered into a global strategic collaboration with Bristol-Myers Squibb (BMS),...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","VXUS","BK1574","159938","06978","159992","BK4588","BK1515","09939","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132270420","title":"Partner Inhibrx Reports Positive CRC Data for Ozekibart and Submits US BLA for Chondrosarcoma Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1132270420","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132270420?lang=en_us&edition=fundamental","pubTime":"2026-05-21 06:28","pubTimestamp":1779316114,"startTime":"0","endTime":"0","summary":"Partner Inhibrx Biosciences, Inc. has reported positive interim data from a Phase 1/2 study evaluating ozekibart in combination with FOLFIRI for patients with locally advanced or metastatic,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","159938","09939","BK1574","CRC","LU0456854461.SGD","LU0266512127.USD","06628","BK4213","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192607908","title":"GENFLEET-B Shares Surge Following Clinical Trial Acceptance and Positive Analyst Coverage","url":"https://stock-news.laohu8.com/highlight/detail?id=1192607908","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192607908?lang=en_us&edition=fundamental","pubTime":"2026-05-20 11:30","pubTimestamp":1779247831,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) saw its shares rise over 6% during the trading session. At the time of reporting, the stock was up 4.62%, trading at HKD 35.80 with a turnover of HKD 17.952 million. The latest...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0183","BK0188","02595","BK1161","BK0028","BK0276","600369","159938","BK1515","BK1574","09939","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161345000","title":"GENFLEET-B Shares Surge Over 6% Following Clinical Trial Acceptance for Dual-Antibody Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=1161345000","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161345000?lang=en_us&edition=fundamental","pubTime":"2026-05-20 11:20","pubTimestamp":1779247226,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) saw its shares rise more than 6% in morning trading. As of the latest update, the stock was up 5.08%, trading at HK$35.96 with a turnover of HK$16.82 million. The movement follows...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1223083913.SGD","BK1515","159938","LU1223082519.USD","BK1161","02595","BK1574","BK4588","BK4017","09939","CDE","BK4585","VXUS","LU1223082196.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156528302","title":"Major Hong Kong Stock Indices Close Lower, One Biotech Stock Soars Over 150% in Late Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1156528302","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156528302?lang=en_us&edition=fundamental","pubTime":"2026-05-18 19:11","pubTimestamp":1779102700,"startTime":"0","endTime":"0","summary":"Hong Kong's stock market experienced a day of volatile trading, ending with declines across its three major indices. At the close, the Hang Seng Index was down 1.11% at 25,675.18 points, the Hang...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","BK1574","BK4585","BK4588","VXUS","BK1515","BK1161","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164324007","title":"Zhenxiang Pharma Reports Meager Revenue of 355k Amidst 290 Million Loss: Weak Solvency and 13 Director Departures Pre-Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1164324007","media":"Deep News","labels":["executive","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164324007?lang=en_us&edition=fundamental","pubTime":"2026-05-18 08:31","pubTimestamp":1779064315,"startTime":"0","endTime":"0","summary":"Recently, Zhenxiang Pharma (Nanjing) Group Co., Ltd. (referred to as Zhenxiang Pharma) submitted an application to the Hong Kong Stock Exchange to pursue a listing, with China International Capital...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"executive,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","BK1574","BK1161","BK1515","09939","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168432876","title":"Southwest Securities Initiates Coverage on GenFleet Therapeutics, Recommends Active Attention Due to Global Leadership in Product Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=1168432876","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168432876?lang=en_us&edition=fundamental","pubTime":"2026-05-17 11:10","pubTimestamp":1778987428,"startTime":"0","endTime":"0","summary":"Southwest Securities has issued a research report stating that GenFleet Therapeutics (02595) is targeting major therapeutic areas such as pancreatic cancer, non-small cell lung cancer, and cachexia...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","BK1515","BK0183","BK0188","159938","09939","600369","BK0276","BK1574","BK0012","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183200699","title":"Southwest Securities Initiates Coverage on GENFLEET-B, Recommends Active Monitoring for Its Leading Global Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=1183200699","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183200699?lang=en_us&edition=fundamental","pubTime":"2026-05-15 17:41","pubTimestamp":1778838084,"startTime":"0","endTime":"0","summary":"Southwest Securities has released a research report initiating coverage on GENFLEET-B (02595), recommending active investor attention. The report highlights the company's strategy of targeting large...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0012","02595","BK0028","BK1515","BK1161","BK0188","BK0183","159938","09939","600369","BK1574","BK0276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138294086","title":"Liban Pharmaceuticals' Second Attempt at Hong Kong Listing: Sole Product Licensed from Roche, In-House Pipeline Far from Market, Core Asset Lacks Competitive Edge","url":"https://stock-news.laohu8.com/highlight/detail?id=1138294086","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138294086?lang=en_us&edition=fundamental","pubTime":"2026-05-15 17:01","pubTimestamp":1778835691,"startTime":"0","endTime":"0","summary":"Recently, Liban Pharmaceuticals, an innovative drug company focused on kidney diseases, has once again submitted a listing application to the Hong Kong Stock Exchange, marking its second attempt...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1161","HEXmain","159938","09939","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179322129","title":"Denaro Pharma-B Announces IPO Subscription Period from May 14 to 19, Anticipates May 22 Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1179322129","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179322129?lang=en_us&edition=fundamental","pubTime":"2026-05-14 07:00","pubTimestamp":1778713232,"startTime":"0","endTime":"0","summary":"Denaro Pharma-B (Stock Code: 06872) will open its initial public offering (IPO) subscription from May 14 to May 19, 2026. The company plans a global offering of 8,280,550 shares, with 10% allocated...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","09939","BK1161","159938","BK1515","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102874861","title":"China Securities' Mid-2026 Pharmaceutical Investment Strategy: Differentiation and Global Value Realization","url":"https://stock-news.laohu8.com/highlight/detail?id=1102874861","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102874861?lang=en_us&edition=fundamental","pubTime":"2026-05-13 11:48","pubTimestamp":1778644117,"startTime":"0","endTime":"0","summary":"According to a research report from China Securities Co., Ltd., the pharmaceutical industry is expected to bottom out and recover in the first half of 2026. Multiple innovative drug companies are...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1515","601066","BK1574","159938","09939","BK0276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166402898","title":"Wanlian Securities: Q1 2026 Public Fund Healthcare Holdings Concentrate on Innovation Chain, Suggest Focus on Biotech and Major Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=1166402898","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166402898?lang=en_us&edition=fundamental","pubTime":"2026-05-13 10:43","pubTimestamp":1778640186,"startTime":"0","endTime":"0","summary":"Wanlian Securities released a research report stating that as of Q1 2026, the structure of public fund holdings in the healthcare sector continues to concentrate towards the innovation chain,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","XBI","BK1574","161027","09939","BK1161","BK1515","BK4588","HBImain","BK4585","BK4581","159837"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175800418","title":"Pharmaceutical Retail Sector Shows Clear Turnarounds in Performance and Valuation, Awaiting Multiple Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=1175800418","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175800418?lang=en_us&edition=fundamental","pubTime":"2026-05-13 07:55","pubTimestamp":1778630108,"startTime":"0","endTime":"0","summary":"CITIC Securities points out that the traditional Chinese medicine (TCM) sector is expected to see short-term base pressure ease. Companies are actively promoting channel reforms and improving quality...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","159938","601066","BK0276","09939","BK1515","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132162078","title":"Fruit and Vegetable Giant's $700 Million Foray into Pharmaceuticals: Can New Controlling Shareholder Turn the Tide?","url":"https://stock-news.laohu8.com/highlight/detail?id=1132162078","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132162078?lang=en_us&edition=fundamental","pubTime":"2026-05-12 17:24","pubTimestamp":1778577897,"startTime":"0","endTime":"0","summary":"The A-share market has maintained a high level of activity in mergers and acquisitions since 2026. According to Wind data, over 130 companies disclosed progress related to M&A activities in the first...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK1574","159938","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126398696","title":"GTHT: Favorable Industry Trends Persist in 1Q26, Innovative Drugs Remain Key Driver of Pharmaceutical Sector Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1126398696","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126398696?lang=en_us&edition=fundamental","pubTime":"2026-05-12 16:10","pubTimestamp":1778573444,"startTime":"0","endTime":"0","summary":"According to a research report from Guotai Haitong (GTHT), the overall revenue of large pharmaceutical companies, small and medium-sized pharmaceutical enterprises, and commercialized biotech firms...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK0012","159938","02611","BK0184","BK0276","BK1147","BK1515","BK0183","BK1161","BK1564","601211","BK0201","159992","BK0188","BK0028","BK1574","06978"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"stockEarnings":[{"period":"1week","weight":-0.0273},{"period":"1month","weight":-0.0561},{"period":"3month","weight":-0.0776},{"period":"6month","weight":-0.0887},{"period":"1year","weight":-0.0381},{"period":"ytd","weight":-0.0663}],"compareEarnings":[{"period":"1week","weight":-0.0054},{"period":"1month","weight":0.0016},{"period":"3month","weight":0.0076},{"period":"6month","weight":0.0725},{"period":"1year","weight":0.2168},{"period":"ytd","weight":0.0363}],"serverTime":1779519772101,"compareStock":{"symbol":"000001.SH","name":"SSE Comp"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS(159938),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS(159938) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS,159938,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股票,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股票老虎,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股票老虎国际,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS行情,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股票行情,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股价,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股市,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股票价格,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股票交易,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股票购买,GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS(159938),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest GF MEDICINE AND HEALTH CARE ALL TRANSACTIONAL OPEN INDEX OF SECURITIES INVESTMENT FUNDS(159938) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction